DEONTIX
An ILM Health Inc Company
"Mental Healthcare Access for Every Person"
Illinois Medicaid Members Served at Launch
1.7M
50%+
Medicaid Members with Untreated Mental Illness
55%+
Patient Engagement Rate vs. 3% Industry Average
76%
SMI Enrollees with At Least One Chronic Condition
About DEONTIX
DEONTIX is the dedicated mental health subsidiary of ILM Health Inc., led by its President, Dr. Gerald I. Hurowitz, MD, MA. DEONTIX serves as the clinical arm through which ILM Health coordinates and delivers prescribed mental health services for Medicaid members across Illinois — fully integrated into ILM's behavioral science engagement and care coordination platform.
Mental illness is the invisible epidemic in Medicaid populations — undertreated, underdiagnosed, and overwhelmingly concentrated among those least able to advocate for themselves. More than 50% of Medicaid members with mental health conditions receive no treatment at all. DEONTIX exists to change that. By removing every structural barrier — transportation, geography, specialist access, stigma — DEONTIX brings evidence-based mental health screening, diagnosis, and ongoing care directly to patients on any device, at any time.
DEONTIX is launching now across Illinois Adult Medicaid — ILM's initial accessible market of 1.7 million members — through ILM's exclusive contracted partnership with PHM Health Strategies.
"In Medicaid populations, mental illness is the invisible epidemic — undertreated, underdiagnosed, and overwhelmingly concentrated among those least able to advocate for themselves."
Our Leadership
Gerald I. Hurowitz, MD, MA - President, DEONTIX Inc
Dr. Hurowitz is a visionary physician-entrepreneur with more than four decades of experience at the intersection of psychiatry, psychopharmacology, and health technology. A graduate of Yale University, he earned his medical degree from Sidney Kimmel Medical College at Thomas Jefferson University — receiving the Baldwyn L. Kayes Prize in Psychiatry upon graduation — and completed his psychiatric residency at NYU/Bellevue. He has served as Assistant Professor of Clinical Psychiatry at Columbia University College of Physicians and Surgeons for more than 30 years, and holds an MA in Philosophy from the NYU Graduate School of Arts & Science.
Dr. Hurowitz is perhaps best known in health technology as Co-Founder and Chief Medical Officer of M3 Information, where he helped develop and commercialize the M3 Checklist (My Mood Monitor)— the only clinically validated, multi-dimensional mental health screening tool proven to simultaneously assess risk for major depression, bipolar disorder, anxiety disorder, and PTSD in a single three-minute assessment. The M3 Checklist was validated through research published in the Annals of Family Medicine and represents a breakthrough in addressing a long-standing gap in primary care: over 70% of mood disorder cases present first in non-psychiatric settings, yet existing tools screened for only one condition at a time.
At DEONTIX, Dr. Hurowitz is positioned to translate decades of clinical insight and proven health technology innovation into a platform that transforms how mental health is detected, delivered, and experienced — for everyone.
Our Clinical Services Partners
DEONTIX – A Total Mental Health Solution
- M3 Checklist Screening - (M3 Information over 2.5 million screens administered)
The only clinically validated multi-disorder screening tool that simultaneously identifies depression, anxiety, bipolar disorder, and PTSD in a single three-minute assessment — completed on any device, with no appointment required. - Remote Psychiatry (Frontier Psychiatry - A leader in Medicaid specific tele-psychiatry)
Board-certified psychiatrists deliver diagnosis, medication management, and treatment planning via secure telehealth — on the patient's schedule, from the patient's home. No transportation. No waiting rooms. No geography. - Remote Counseling (Talkspace - America's #1 rated online therapy company)
Licensed counselors deliver CBT, motivational interviewing, and trauma-informed therapy via secure video — accessible on any device, meeting patients wherever they are in their mental health journey. - Mental Health Self Management - (Wisdo Health - Clinically proven Social Health Platform)
Coordinated Care Planning
Personalized mental health care plans coordinated across the behavioral health team, primary care physicians, and pharmacy — with ongoing monitoring and re-screening to detect deterioration early.
How We Work
01 Removing Barriers to Access
No transportation needed. No office visit required. DEONTIX's platform connects patients to care through any device — meeting people with mobility challenges, without childcare, or working multiple jobs exactly where they are.
02 Behavioral Science-Driven Engagement
ILM's proprietary persona engine segments patients by demographics, psychographics, cultural affinities, and behavioral bias — ensuring every touchpoint drives engagement, adherence, and compliance. Not a form letter. A system that sees each patient as an individual.
03 Trauma-Informed, Culturally Responsive Care
Every care pathway is built on trauma-informed principles. ILM's engagement engine personalizes every touchpoint by cultural affinity, language preference, and behavioral profile — delivering care that meets each patient as a whole person.
04 Continuous Care, Not a One-Time Event
DEONTIX prompts regular re-screening, monitors for deterioration, and maintains the patient relationship over time — transforming fragmented encounters into a continuous, trusted care presence.
The Problem We're Solving
Adults with serious mental illness (SMI) — such as schizophrenia or bipolar disorder — cost Medicaid approximately three times more per year than those without a mental illness. Approximately 76% of SMI enrollees have at least one additional chronic condition. Yet despite driving a disproportionate share of total Medicaid spending, the majority of these individuals receive no mental health treatment.
- No mental illness : ~ $7,000
- Any mental illness : ~ $14,000 (2x higher)
- Serious mental illness (SMI) : ~ $21,000 (3x higher)
Most of that extra spending is not on psychiatric care directly — it is on the physical health conditions that tend to co-occur and go unmanaged when mental illness goes untreated. Early intervention is not just the right thing to do. It is the economically rational response. DEONTIX and ILM's broader Digital Network break that cycle — improving outcomes for individuals while demonstrably reducing the cost burden on the communities and systems that serve them.
Our Partnership
DEONTIX delivers mental health services as the dedicated clinical subsidiary within ILM Health's Digital Network. ILM Health is the exclusive engagement and care coordination partner of PHM Health Strategies — the organization spearheading Medicaid Transformation in Illinois. Together, ILM, DEONTIX, and PHM Health Strategies have an initial accessible market of 1.7 million members, with a shared roadmap to expand this model into additional states.
Clinical services coordinated through DEONTIX are always prescribed and directed by the appropriate authority — States, FQHCs, hospital groups, and physicians. DEONTIX brings the clinical expertise, the validated screening infrastructure, and world-class provider partnerships. ILM Health brings the behavioral science engagement platform and care coordination. Together, they deliver what this population has never had: continuous, personalized, accessible mental healthcare.